Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fugan ointment in subacute eczema
CTR20132041Phase 2Completed
- Sponsor
- Chengdu Baiter Pharmaceutical Co., Ltd.
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ZL-3101 in atopic dermatitis (AD), sponsored by Chengdu Baiter Pharmaceutical Co., Ltd.. Started Aug 2015; status: completed.
02
Drugs
ZL-3101
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on CTR20132041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132041.